Sector
PharmaceuticalsOpen
₹2,377.8Prev. Close
₹2,375.2Turnover(Lac.)
₹26,226.6Day's High
₹2,464.9Day's Low
₹2,377.852 Week's High
₹2,716.552 Week's Low
₹1,909.7Book Value
₹386.64Face Value
₹1Mkt Cap (₹ Cr.)
1,00,350.31P/E
55.5EPS
42.8Divi. Yield
0The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.
Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.
The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.
Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.
The cumulative demand, including interest charges, is ₹183.11 crore.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 41.26 | 40.06 | 40.06 | 40.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 14,599.01 | 9,662.71 | 7,743.85 | 6,500.39 |
Net Worth | 14,640.27 | 9,702.77 | 7,783.91 | 6,540.45 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 | 6,214.43 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 12,207.44 | 10,260.44 | 8,749.43 | 7,781.56 | 6,214.43 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 553.56 | 296.41 | 140.99 | 210.48 | 182.63 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,847.9 | 100.85 | 4,40,134.01 | 705.44 | 0.87 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,710.5 | 69.14 | 1,77,883.86 | 598 | 0.45 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,380.8 | 66.05 | 1,47,526.68 | 577 | 0.14 | 2,547 | 249.82 |
Lupin Ltd LUPIN | 2,379.5 | 20.34 | 1,12,463.67 | 2,163.69 | 0.49 | 5,152.26 | 595.44 |
Cipla Ltd CIPLA | 1,347 | 24.03 | 1,10,088.66 | 616.88 | 1.17 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Wholetime Director
RAMESH CHAND JUNEJA
Vice Chairman & Managing Director
RAJEEV JUNEJA
Whole Time Director & Chief Executive Officer
SHEETAL ARORA
Independent Director
TILOKCHAND PUNAMCHAND OSTWAL
Independent Director
Bharat Anand
Whole-time Director
SATISH KUMAR SHARMA
Independent Director
Vivek Kalra
Independent Director
Vijaya Sampath
Company Sec. & Compli. Officer
Hitesh Kumar Jain
208 Okhla Industrial Estate,
Phase-III,
New Delhi - 110020
Tel: 91-11-47476600
Website: http://www.mankindpharma.com
Email: investors@mankindpharma.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@karvy.com
Summary
Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi. Purs...
Read More
Reports by Mankind Pharma Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.